HOUSTON--(BUSINESS WIRE)--Dec. 27, 2005--CytoGenix, Inc. (OTCBB:CYGX) announced today the signing of a contract with the Fast Trak BioDefense group of GE Healthcare, a unit of General Electric Company (NYSE:GE). GE Healthcare’s Fast Trak BioDefense group has a diverse staff of highly qualified technical and regulatory experts who will collaborate with CytoGenix in seeking, obtaining and executing bio-defense related federal contracts. Frank Vazquez, CytoGenix, Inc. Executive Vice President and COO commented, “Our association with GE Healthcare, a $14 Billion entity of GE, as partners in competing for federal research projects sends a very positive message to grant reviewers and granting agencies at the Department of Homeland Security, the Department of Defense and the Department of Health and Human Services. We are very excited about this relationship and expect to see very positive results soon.”
